XML 22 R12.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Note 5 - Stock-based Compensation
3 Months Ended
Mar. 31, 2024
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

5.

STOCK-BASED COMPENSATION

 

At March 31,2024, we had two stock-based compensation plans in effect. We record compensation cost related to unvested stock awards by recognizing the unamortized grant date fair value on a straight-line basis over the vesting periods of each award. We have estimated forfeiture rates based on our historical experience. Stock compensation expense for the three-month periods ended March 31, 2024 and 2023 has been recognized as a component of general and administrative expenses in the accompanying Consolidated Financial Statements. We recorded $160,000 and $0 of stock-based compensation expense during the quarters ended March 31, 2024 and 2023, respectively.

 

Stock Options

 

As of March 31, 2024, there was no unrecognized compensation cost related to stock options. There were no options exercised during the three months ended March 31, 2024 or 2023. No options were granted during the three months ended March 31, 2024 or 2023. The following table summarizes options as of March 31, 2024:

 

Options Outstanding and Exercisable:

                         

Range of
Exercise Price

   

Number
Outstanding

   

Wgt. Avg. Contractual
Life Remaining

(in years)

   

Wgt. Avg.
Exercise Price

   

Aggregate
Intrinsic Value

 

$3.50

$3.86       13,000       3.0     $ 3.75     $ 94,910  
    $7.80         8,000       4.2     $ 7.80     $ 26,000  
    $19.99         30,000       4.8     $ 19.99     $ -  
    $39.11         8,000       5.2     $ 39.11     $ -  

$3.50

$39.11       59,000       4.4     $ 17.35     $ 120,910  

 

 

The estimated fair value of options granted is calculated using the Black-Scholes option pricing model with assumptions as previously disclosed in our 2023 Form 10-K.

 

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price on the last trading day of the first quarter of 2024 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on March 31, 2024. The amount of aggregate intrinsic value will change based on the market value of the Company’s stock.

 

Restricted Stock Units

 

Restricted Stock Units, or RSUs, generally vest at the end of a three-year vesting period. A summary of the Company’s RSU activity was as follows:

 

   

Number of Restricted

Stock Units

   

Weighted-average grant

date fair value per share

 

Balance as of December 31, 2023

    -     $ -  

Granted

    287,484       12.34  

Vested

    -       -  

Canceled and forfeited

    -       -  

Balance as of March 31, 2024

    287,484     $ 12.34  

 

As of March 31, 2024, unrecognized compensation costs related to unvested RSUs was $3.1 million, which we expect to recognize over a weighted-average period of 2.9 years.